QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, announced on Monday the launch of their enhanced QIAGEN CLC Genomics Workbench Premium. The innovation removes the data-analysis bottleneck of next-generation sequencing (NGS) by adding game-changing analysis speed to analyze and interpret whole genome sequencing (WGS), whole exome sequencing (WES) and large panel sequencing data.
Processing a whole genome in 25 minutes
The update to QIAGEN CLC Genomics Workbench Premium incorporates LightSpeed technology, a software accelerator that, at unprecedented speed, converts raw sequencing data in FASTQ files from any paired-end short read sequencing platform into interpretable lists of genetic variants in the VCF format. It can analyze an entire human genome at 34x coverage on an ordinary computer in just 25 minutes and a 50x whole exome in 90 seconds within standard cloud environments.
With QIAGEN CLC LightSpeed technology, laboratories can run WGS analyses for around $1 per genome and WES for less than a few cents per exome using cloud infrastructure. Alternatively, labs can efficiently run the QIAGEN CLC LightSpeed technology on existing local hardware with similar performance.
Dr. Jonathan Sheldon, Senior Vice President of QIAGEN Digital Insights:
“QIAGEN CLC Genomics Workbench Premium is much faster, more accurate, greener and cheaper than previous data-analysis and visualization solutions. Thanks to LightSpeed’s ground-breaking technology, WGS analysis is extremely fast, beats most other FASTQ to VCF workflows on accuracy, uses less power and requires no investments in new hardware or software licenses beyond CLC.”
QDI’s investment in the LightSpeed technology is ideally suited to NGS areas such as neonatal screening for hereditary diseases or large population-genomics studies in which speed and cost are priorities. This enhancement in CLC Genomics secondary analysis software demonstrates QIAGEN’s continued leadership and commitment to targeted growth areas, including WGS and WES.
Jonathan Sheldon added:
“LightSpeed will allow QDI to maintain its leadership position in data analysis as the market moves away from analyzing a few hundred selected genes to comprehensive genetic testing. Its cost and time efficiency gives high-throughput NGS sequencing laboratories the chance to use the technology widely for clinical and research clients. The quicker unwanted mutations are spotted, the sooner associated diseases can be identified and treated.”
QDI’s licensing models enable laboratories to analyze WGS and WES samples simultaneously. Their QIAGEN CLC Genomics Workbench Premium is a cost-saving, scalable solution that can analyze NGS data from any sequencing platform and runs locally, on a server or in the cloud.
Learn more about the LightSpeed technology now available from QIAGEN CLC Genomics Workbench Premium: https://digitalinsights.qiagen.com/news/blog/discovery/analyze-whole-genome-sequencing-samples-at-the-speed-of-light/
About QIAGEN Digital Insights
QIAGEN Digital Insights, the bioinformatics business of QIAGEN, is the leading provider of genomic and clinical knowledge, analysis and interpretation tools and services for scientists and clinicians. We have over 25 years of experience in the industry, 90,000 users worldwide, over 100,000 citations in scientific papers, more than 3 million profiled patient cases and over 40 billion scientific data points. Discover our portfolio of expertly curated genomic and clinical knowledge solutions as well as bioinformatics software and services for efficient data management, sharing and actionable insights.
No listings were found matching your selection.